top of page
Akthelia News Desk
Oct 17, 2024
Akthelia Pharmaceuticals Awarded RANNIS Grant to Accelerate Development of Gastrimod® (AKT-011) for Chemotherapy-Induced FN
Akthelia Pharmaceuticals is pleased to announce it has been awarded a two-year $350,000 research grant by RANNIS
Akthelia News Desk
Sep 8, 2024
Akthelia Pharmaceuticals presents new translational mucosal barrier injury efficacy data at NLSD 2024
Akthelia Pharma will present exciting new translational data, and partnering and capital raising objectives at Nordic Life Science Days 2024
bottom of page